Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled with Metformin; A Narrative Review. (2020). Indian Journal of Public Health Research & Development, 11(7), 1063-1069. https://doi.org/10.37506/ijphrd.v11i7.10232